Crescent Biopharma, Inc.
CBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001253689
In the last 90 days, Crescent Biopharma, Inc. insiders filed 1 open-market purchase and 7 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $532.6M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Crescent Biopharma, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −6 vs. Q1 2022
- Shares held
- 26.5M
- −857.5K (−3.1%) vs. Q1 2022
- Total value
- $15.8M
- −$15.3M (−49.2%) vs. Q1 2022
- New holders
- 3
- 5 more added
- Sold out
- 9
- 15 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $532.6M |
| Q1 2026 | 63 | $476.6M |
| Q4 2025 | 58 | $285.9M |
| Q3 2025 | 41 | $134.6M |
| Q2 2025 | 30 | $173.5M |
| Q1 2025 | 35 | $6.46M |
| Q4 2024 | 41 | $7.56M |
| Q3 2024 | 36 | $3.00M |
| Q2 2024 | 35 | $7.20M |
| Q1 2024 | 69 | $110.5M |
| Q4 2023 | 58 | $82.8M |
| Q3 2023 | 49 | $52.1M |
| Q2 2023 | 55 | $61.9M |
| Q1 2023 | 54 | $46.6M |
| Q4 2022 | 48 | $83.3M |
| Q3 2022 | 35 | $14.3M |
| Q2 2022 | 37 | $15.8M |
| Q1 2022 | 44 | $31.2M |
| Q4 2021 | 47 | $42.7M |
| Q3 2021 | 48 | $64.9M |
| Q2 2021 | 58 | $72.5M |
| Q1 2021 | 78 | $110.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Crescent Biopharma, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 10 | $0 | 0.00% | −4,109−99.8% | Reduced |
| JPMorgan Chase & Co | 1 | $0 | 0.00% | −1,467−99.9% | Reduced |
| Wells Fargo & Company | 281 | $0 | 0.00% | +26+10.2% | Added |
| Carolinas Wealth Consulting LLC | 395 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 600 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 481 | $288 | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 2,000 | $1.00K | 0.00% | +2,000 | New |
| Hartford Financial Management Inc. | 3,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 5,063 | $3.00K | 0.00% | −212,053−97.7% | Reduced |
| Commonwealth Equity Services, LLC | 10,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 9,304 | $6.00K | 0.00% | −6,500−41.1% | Reduced |
| Citadel Advisors LLC | 10,796 | $6.00K | 0.00% | −1,723−13.8% | Reduced |
| Tower Research Capital LLC (TRC) | 9,574 | $6.00K | 0.00% | +7,582+380.6% | Added |
| Prentiss Smith & Co Inc | 14,000 | $8.00K | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 17,618 | $11.0K | 0.00% | −30,022−63.0% | Reduced |
| Jane Street Group, LLC | 19,154 | $11.0K | 0.00% | +19,154 | New |
| Bank of New York Mellon Corp | 26,238 | $16.0K | 0.00% | −61−0.2% | Reduced |
| Ieq Capital, LLC | 38,363 | $23.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 43,620 | $26.0K | 0.00% | −32−0.1% | Reduced |
| Charles Schwab Investment Management Inc | 60,353 | $37.0K | 0.00% | +60,353 | New |
| Intellectus Partners, LLC | 88,000 | $53.0K | 0.02% | −2,500−2.8% | Reduced |
| Northern Trust Corp | 97,797 | $58.0K | 0.00% | 00.0% | Unchanged |
| Eversept Partners, LP | 100,579 | $60.1K | 0.01% | 00.0% | Unchanged |
| Franklin Resources Inc | 119,329 | $71.0K | 0.00% | −41,971−26.0% | Reduced |
| State Street Corp | 148,965 | $89.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 155,400 | $93.0K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 242,023 | $144.0K | 0.00% | −13,661−5.3% | Reduced |
| Two Sigma Advisers, LP | 317,400 | $190.0K | 0.00% | −71,400−18.4% | Reduced |
| Two Sigma Investments, LP | 322,283 | $193.0K | 0.00% | −98,536−23.4% | Reduced |
| Geode Capital Management, LLC | 358,395 | $214.0K | 0.00% | −5,042−1.4% | Reduced |
| Millennium Management LLC | 434,655 | $260.0K | 0.00% | +30,466+7.5% | Added |
| Renaissance Technologies LLC | 566,400 | $339.0K | 0.00% | +95,800+20.4% | Added |
| BlackRock Inc. | 768,333 | $459.0K | 0.00% | −99,904−11.5% | Reduced |
| Vanguard Group Inc | 1,846,762 | $1.10M | 0.00% | +31,799+1.8% | Added |
| Acadian Asset Management LLC | 1,990,087 | $1.19M | 0.01% | 00.0% | Unchanged |
| NEA Management Company, LLC | 9,089,041 | $5.43M | 0.28% | 00.0% | Unchanged |
| BVF Inc | 9,544,262 | $5.71M | 0.28% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −271,129−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −89,926−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −87,678−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −28,004−100.0% | Sold out |
| Sigma Planning Corp | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −10,720−100.0% | Sold out |
| Coastal Bridge Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| FinTrust Capital Advisors, LLC | 0 | $0 | 0.00% | −245−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |